Abstract:
The key to change in the pharmaceutical industry is technology and new drug introductions versus exposure to generic competition. The net effect equals the critical stock selection criterion for pharmaceutical investing.
This could also be of interest:
Case Studies
In-depth pharmaceutical competitor analysis
Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: William Hall
 
February 27, 1985
Research Papers
Competitor analysis
Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Author: Stewart Fairbairn
 
February 27, 1985
Research Papers
Competitor analysis by patient monitoring
Catalogue: EPHMRA/ESOMAR Seminar 1985: Pharmaceutical Competitor Analysis
Authors: Ingrid Köpl, Gerd Bögel
Company: Marplan Forschungsgesellschaft mbH
February 27, 1985
